Candel Therapeutics
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -163 | -195 | -242 | -245 |
EBITDA | -40,120 | -10,913 | -4,318 | 7,930 |
EBIT | -40,283 | -11,108 | -4,560 | 7,685 |
Net Income | -29,496 | -11,269 | -4,796 | 7,379 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -10,977 | -10,380 | -8,922 | -8,619 |
Cash | 119,731 | 86,963 | 100,687 | 92,165 |
Basic Shares | 54,898 | 54,894 | 51,489 | 31,675 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $31 | $125 |
Gross Profit | -845 | -990 | -23,980 | 125 |
EBITDA | -47,421 | -52,097 | -37,431 | -16,308 |
EBIT | -48,266 | -53,087 | -38,391 | -17,086 |
Net Income | -38,182 | -55,177 | -37,939 | -18,794 |
Net Change In Cash | 0 | 0 | 31 | 125 |
Free Cash Flow | -38,898 | -27,039 | -34,701 | -32,716 |
Cash | 119,731 | 102,654 | 35,413 | 70,058 |
Basic Shares | 52,958 | 31,675 | 28,935 | 28,823 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | $0 |
2025-12-31 | -$0.29 |
2025-09-30 | -$0.21 |
2025-06-30 | -$0.09 |
